Literature DB >> 22568974

The impact of gender on urine C-peptide creatinine ratio interpretation.

Nicholas J Thomas1, Beverley M Shields, Rachel E J Besser, Angus G Jones, Andrew Rawlingson, Emily Goodchild, Christopher Leighton, Pamela Bowman, Maggie Shepherd, Bridget A Knight, Timothy J McDonald, Andrew T Hattersley.   

Abstract

BACKGROUND: Urinary C-peptide creatinine ratio (UCPCR) is a non-invasive and convenient way of assessing endogenous insulin production. Adjusting for urine creatinine levels allows for differences in urine concentration. Creatinine excretion is known to be higher in men due to gender differences in muscle mass. We investigated the impact of gender on UCPCR.
METHODS: One hundred and seventy-six subjects underwent a mixed meal tolerance test (MMTT). We looked at the relationship between UCPCR on urine C-peptide and creatinine excretion rates using timed post-meal urine samples. A further 415 subjects had two-hour post-meal UCPCR measurements in order to derive gender-specific percentiles for different diabetes subgroups and controls.
RESULTS: UCPCR was 1.48-fold higher in women (n=78) than men (n=98), median (interquartile range [IQR]): 1.88 (0.49-3.49) men versus 2.88 (1.58-4.91) nmol mmol(-1) women, P=0.01. This reflects a gender difference in creatinine excretion rates (11.5 [8.3-13.7] men versus 8.2 [5.6-9.1] women μmol min(-1) P<0.001). C-peptide excretion rate was similar in men and women (19.8 [5.2-37.0] versus 22.1 [7.4-40.5] pmol min(-1), P=0.7). UCPCR was higher in women in all subgroups defined by diabetes classification and treatment, except long-term type 1 diabetes in whom C-peptide secretion was minimal.
CONCLUSIONS: Gender affects UCPCR, with higher values found in women. This results from lower urine creatinine reflecting gender differences in muscle mass. This necessitates gender-specific ranges for accurate interpretation of UCPCR results.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22568974     DOI: 10.1258/acb.2011.011164

Source DB:  PubMed          Journal:  Ann Clin Biochem        ISSN: 0004-5632            Impact factor:   2.057


  5 in total

Review 1.  The clinical utility of C-peptide measurement in the care of patients with diabetes.

Authors:  A G Jones; A T Hattersley
Journal:  Diabet Med       Date:  2013-07       Impact factor: 4.359

2.  Urinary C peptide creatinine ratio in pregnant women with normal glucose tolerance and type 1 diabetes: evidence for insulin secretion.

Authors:  Ankica Markoska; Rajalakshmi Valaiyapathi; Chloe Thorn; Anne Dornhorst
Journal:  BMJ Open Diabetes Res Care       Date:  2017-01-04

Review 3.  A Practical Review of C-Peptide Testing in Diabetes.

Authors:  Emma Leighton; Christopher Ar Sainsbury; Gregory C Jones
Journal:  Diabetes Ther       Date:  2017-05-08       Impact factor: 2.945

4.  Casual C peptide index: Predicting the subsequent need for insulin therapy in outpatients with type 2 diabetes under primary care.

Authors:  Ryota Uehara; Eijiro Yamada; Yasuyo Nakajima; Aya Osaki; Shuichi Okada; Masanobu Yamada
Journal:  J Diabetes       Date:  2022-03-01       Impact factor: 4.530

5.  Detection of C-peptide in human hair and nail: a comparison between healthy persons and persons with type 1 diabetes.

Authors:  Jamal M Salih; Darya S Abdulateef
Journal:  BMJ Open Diabetes Res Care       Date:  2020-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.